Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
101 participants
INTERVENTIONAL
2024-06-17
2025-01-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Behavioral Weight Loss Treatment vs. Weight Watchers
NCT00249340
Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss
NCT05180448
Improving Quality of Life in Men and Women With Overweight or Obesity
NCT04871295
Study of a Personalized vs. Standard Approach to Weight Loss Recommendations
NCT04639076
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
NCT04520256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meds alone
Participants in this group do not receive behavioral or lifestyle support alongside their medications. The medications are not part of the intervention (it is part of the eligibility criteria).
No interventions assigned to this group
Meds plus WW
Participants in this group receive behavioral or lifestyle support from WW Clinic alongside their medications. The medications are not part of the intervention (it is part of the eligibility criteria).
WW Clinic
Telehealth platform that specializes in medical weight management and integrates the behavioral and lifestyle support from WW
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
WW Clinic
Telehealth platform that specializes in medical weight management and integrates the behavioral and lifestyle support from WW
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Determined eligible for Bupropion/Naltrexone or Liraglutide by WW Clinic medical provider and initiated a medication management plan
Exclusion Criteria
* Uncontrolled hypertension
* History of seizures
* History of glaucoma
* History of chronic kidney disease
* Currently taking bupropion
* Currently taking naltrexone
* Current or previous history of anorexia or bulimia nervosa
* Engagement with vomiting or laxative use within the last 28 days with the aim of controlling their shape or weight
* Currently taking opioids
* Previous surgical obesity treatment
* Use of other anti-obesity medication in last 90 days or a GLP1 in the last 180 days
* Lost weight \>11 lbs in the last 90 days
* Pregnant, breastfeeding, intends to become pregnant, of child-bearing potential and not using a highly effective contraceptive method
* Any other reason rendering a participant unsuitable for trial participation, as determined by a clinician or study investigator
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Michelle Cardel, PhD, MS, RD
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michelle Cardel, PhD, MS, RD
Senior Director of Global Clinical Research and Nutrition
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michelle Cardel, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
WW International Inc
Rebecca Jones, PhD
Role: PRINCIPAL_INVESTIGATOR
WW International Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WW International, Inc
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Meds WOW-WW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.